Praed is a “start in the middle” biopharmaceuticals company founded by industry experts with more than 60 years of combined experience in the pharmaceutical industry. Our goal is to deliver a next generation treatment for Crohn’s disease. We are a company with a clinical Phase II ready compound, which has a fully established CMC (Chemistry, Manufacturing and Control) and safety profile from a Phase III program encompassing 684 patients in another gastro-intestinal indication.
